These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8120116)

  • 21. Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers.
    Rajnarayana K; Venkatesham A; Nagulu M; Srinivas M; Krishna DR
    Drug Metabol Drug Interact; 2008; 23(3-4):311-21. PubMed ID: 19326774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene.
    Haufroid V; Buchet JP; Gardinal S; Lison D
    Int Arch Occup Environ Health; 2002 Sep; 75(7):453-8. PubMed ID: 12172891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of brain cytochrome P450 2E1 activity in rat with the probe of chlorzoxazone by liquid chromatography-mass spectrometry.
    Wu JY; Yue J; Feng YQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(3-4):260-6. PubMed ID: 21196134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct injection analysis of chlorzoxazone and its major metabolite 6-hydroxychlorzoxazone in human serum using a semipermeable surface (SPS) HPLC column.
    Haque A; Stewart JT
    Biomed Chromatogr; 1997; 11(4):236-9. PubMed ID: 9257001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe.
    Park JY; Kim KA; Park PW; Ha JM
    J Clin Pharmacol; 2006 Jan; 46(1):109-14. PubMed ID: 16397290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of chlorzoxazone, indicator of CYP2E1, and its metabolite in human serum using a new reversed-phase chromatographic column of 2-microm porous microspherical silica-gel.
    Tanaka E
    J Pharm Biomed Anal; 1998 Jan; 16(5):899-904. PubMed ID: 9535202
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.
    Frye RF; Adedoyin A; Mauro K; Matzke GR; Branch RA
    J Clin Pharmacol; 1998 Jan; 38(1):82-9. PubMed ID: 9597564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotyping of cytochrome P450 2E1 in vitro and in vivo.
    Ernstgård L; Johanson G; Karlsson AS; Warholm M
    Curr Drug Metab; 2007 Jun; 8(5):493-8. PubMed ID: 17584020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on interindividual variations of CYP2E1 using chlorzoxazone as an in vivo probe.
    Vesell ES; Seaton TD; A-Rahim YI
    Pharmacogenetics; 1995 Feb; 5(1):53-7. PubMed ID: 7773304
    [No Abstract]   [Full Text] [Related]  

  • 30. Determination of 6-hydroxychlorzoxazone and chlorzoxazone in porcine microsome samples.
    Cox SK; Hamner T; Bartges J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 784(1):111-6. PubMed ID: 12504188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
    Poloyac SM; Tosheva RT; Gardner BM; Shedlofsky SI; Blouin RA
    Clin Pharmacol Ther; 1999 Dec; 66(6):554-62. PubMed ID: 10613610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans.
    Berthou F; Goasduff T; Lucas D; Dréano Y; Le Bot MH; Ménez JF
    Pharmacogenetics; 1995 Apr; 5(2):72-9. PubMed ID: 7663531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population.
    Chen XP; Han XM; Jiang CH; Huang SL; Liu ZQ; Zhu B; Zhou G; Zhou HH
    Xenobiotica; 2002 Nov; 32(11):1053-62. PubMed ID: 12487734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats.
    Wan J; Ernstgård L; Song BJ; Shoaf SE
    J Pharm Pharmacol; 2006 Jan; 58(1):51-61. PubMed ID: 16393464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the fragmentation mechanism of protonated 6-hydroxychlorzoxazone: application in simultaneous analysis of CYP2E1 activity with major human cytochrome P450s.
    Anari MR; Bakhtiar R; Franklin RB; Pearson PG; Baillie TA
    Anal Chem; 2003 Feb; 75(3):469-78. PubMed ID: 12585472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validated HPLC method for determination of chlorzoxazone in human serum and its application in a clinical pharmacokinetic study.
    Rajnarayana K; Mada SR; Vidyasagar J; Kishore P; Krishna DR
    Pharmazie; 2002 Dec; 57(12):811-3. PubMed ID: 12561241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics.
    Girre C; Lucas D; Hispard E; Menez C; Dally S; Menez JF
    Biochem Pharmacol; 1994 Apr; 47(9):1503-8. PubMed ID: 7910460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of CYP2E1 activity in diabetic rat model].
    Li L; Zhang Y
    Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans.
    Zand R; Nelson SD; Slattery JT; Thummel KE; Kalhorn TF; Adams SP; Wright JM
    Clin Pharmacol Ther; 1993 Aug; 54(2):142-9. PubMed ID: 8354023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.